Actively Recruiting
Omitting Radiation Therapy After Lumpectomy in Women with Clinically Node Negative Breast Cancer Showing Complete Response After Chemotherapy
Led by Ontario Clinical Oncology Group (OCOG) · Updated on 2026-10-13
352
Participants Needed
27
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety of omitting adjuvant whole breast radiation therapy WBRT in women with breast cancer who have no clinical lymph node involvement and have achieved a complete pathological response after neoadjuvant chemotherapy. This prospective, multi-center, single arm cohort study focuses on women with newly diagnosed T1-3 node negative breast cancer treated with breast conserving surgery and axillary staging. The study aims to observe breast tumor recurrence and survival outcomes over a median 5-year follow-up period. Participants will not receive the standard adjuvant WBRT after surgery. Instead, they will be closely monitored for any recurrence or progression of breast cancer. The study includes women who have undergone a minimum of eight weeks of neoadjuvant chemotherapy, breast conserving surgery with complete tumor bed excision, and axillary staging surgery. The absence of residual invasive or in situ cancer pathological complete response in the breast and lymph nodes is required for enrollment. During the study, participants will be followed regularly to assess ipsilateral breast tumor recurrence, local and regional recurrence, distant recurrence, disease-free survival, and overall survival. Any additional treatments received for recurrence such as repeat surgery, systemic therapy, or radiation will be documented. The total study duration extends up to five years from enrollment, with researchers evaluating tumor recurrence as the primary outcome at the median five-year mark.
CONDITIONS
Brief Title
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
Research Team
A
Adrianne Van Dam
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here